Henry Scott Patent Quotations

This approval takes some risk out of the equation for them. If they can get the production capacity, it has the potential to be a significant drug. The big issue for Bristol is patent expirations and whether the pipeline can offset them.

I still believe Pfizer will win the U.S. case, but you can never make any assumptions in a patent dispute.